Clinical trial

Docetaxel and Cetuximab in Treating Patients With Metastatic Prostate Cancer

NCT00728663

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-06-01

PhasePHASE2

Study timeline

Study start (unknown)2008-06-01Date precision: month

Registry last updated2019-05-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

cetuximabBIOLOGICAL

docetaxelDRUG · verified · RxNorm: docetaxel

Sponsors & collaborators

Swiss Cancer Institutelead sponsor

Mapped research locations

ZurichSwitzerland4 BaselSwitzerland2 BernSwitzerland1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00728663 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.